Answer
The mean half-life of guselkumab in patients with plaque psoriasis is approximately 15 to 18 days across studies.
Sources for this answer
- Tremfya 100 mg OnePress solution for injection in pre-filled penJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §5.2 Pharmacokinetic properties · Version 16Document updated
Sources checked